Sm. Gardiner et al., ENHANCEMENT OF THE HYPOTENSIVE AND VASODILATOR EFFECTS OF ENDOTOXEMIAIN CONSCIOUS RATS BY THE ENDOTHELIN ANTAGONIST, SB-209670, British Journal of Pharmacology, 116(2), 1995, pp. 1718-1719
In conscious, chronically-instrumented rats, the non-selective endothe
lin antagonist, SB 209670 (10 mu g kg(-1) min(-1)), caused marked enha
ncement of the fall in mean arterial blood pressure during infusion of
lipopolysaccharide (LPS) for 24h (LPS alone = -6 +/- 3 mmHg; LPS + SB
209670 = -30 +/- 2 mmHg). This effect was accompanied by a conversion
of the mesenteric vasoconstriction to a substantial mesenteric vasodi
latation and an augmentation of the hindquarters vasodilatation, seen
with LPS alone. Notably, the marked renal hyperaemic vasodilatation du
ring LPS infusion was not affected significantly by SB 209670. These r
esults indicate that endothelin, directly and/or indirectly, plays a p
ivotal role in the cardiovascular sequelae of endotoxaemia in consciou
s rats, and prevents marked hypotension, particularly by opposing mese
nteric vasodilatation.